Legal Representation
Attorney
Karen S. Frank
USPTO Deadlines
Application History
11 eventsDate | Code | Type | Description |
---|---|---|---|
Jan 30, 2023 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Jan 30, 2023 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Jan 30, 2023 | MAB2 | E | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Jun 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
Jun 28, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jun 28, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED |
Jun 28, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jan 7, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED |
Jan 7, 2022 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
Oct 27, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Oct 1, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Medical diagnostic test kits comprised of medical diagnostic reagents and assays for testing blood for use in cancer therapy evaluation and transplantation monitoring and transplantation therapy evaluation
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Loading USPTO documents...